1.23

1.60% -0.02

NKGen Biotech Inc (NKGN)

Überblick Nachrichten Preisverlauf Warum fällt NKGN? Forum Prognose

Schlusskurs vom Vortag:

$1.25

Offen:

$1.23

24-Stunden-Volumen:

51,430

Marktkapitalisierung:

$27.89M

Einnahmen:

Nettoeinkommen (Verlust:

KGV:

EPS:

Netto-Cashflow:

1W Leistung:

-13.99%

1M Leistung:

-2.38%

6M Leistung:

-57.88%

1J Leistung:

+0.00%

1-Tages-Spanne:

$1.23

$1.3199

52-Wochen-Spanne:

$0.7802

$6.70

NKGen Biotech Inc Stock (NKGN) Company Profile

Firmenname

NKGen Biotech Inc

Sektor

Healthcare (1222)

Branche

Biotechnology (696)

Telefon

346-442-0819

Adresse

1790 Hughes Landing Boulevard, Suite 400, The Woodlands

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NKGN's Discussions on Twitter

NKGen Biotech Inc Aktie (NKGN) Neueste Nachrichten

NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

GlobeNewswire Inc.

NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire Inc.

NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

GlobeNewswire Inc.

NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs

GlobeNewswire Inc.

NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer’s Disease at the Tau2024 Global Conference

GlobeNewswire Inc.

Trading Penny Stocks With $1,000, Top Tips

PennyStocks

Finanzdaten der NKGen Biotech Inc-Aktie (NKGN)

Es liegen keine Finanzdaten für NKGen Biotech Inc (NKGN) vor. Überprüfen Sie andere Aktien für weitere Informationen.

BMRN

$80.88

1.05%

BGNE

$161.48

4.37%

GMAB

$28.80

0.00%

ALNY

$150.32

0.72%

ARGX

$378.17

1.16%

BNTX

$91.96

0.15%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen

NKGen Biotech Inc (NKGN)

NKGen Biotech Inc Stock (NKGN) Company Profile

NKGen Biotech Inc Aktie (NKGN) Neueste Nachrichten

NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs

NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer’s Disease at the Tau2024 Global Conference

Trading Penny Stocks With $1,000, Top Tips

Finanzdaten der NKGen Biotech Inc-Aktie (NKGN)

Ähnlich wie NKGN